newsfilter
← Latest News
Business Wire·

New Data Analysis Supports GOCOVRI as an Important Treatment for Motor Complications for People With Parkinson's Disease

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the publication of a new data analysis titled, "Effects